A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD (TAP2)
Sponsor: Northern California Institute of Research and Education
Listed as NCT01749215, this PHASE4 trial focuses on Alcohol Dependence and Posttraumatic Stress Disorder (PTSD) and remains completed. Sponsored by Northern California Institute of Research and Education, it has been updated 13 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE4
-
Sep 2021 — Dec 2022 [monthly]
Completed PHASE4
▶ Show 8 earlier versions
-
May 2021 — Sep 2021 [monthly]
Completed PHASE4
-
Jan 2021 — May 2021 [monthly]
Completed PHASE4
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE4
-
Sep 2019 — Nov 2020 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Nov 2018 — Sep 2019 [monthly]
Recruiting PHASE4
-
Jun 2018 — Nov 2018 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Feb 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Northern California Institute of Research and Education
- San Francisco Veterans Affairs Medical Center
- United States Department of Defense
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .